Immunohistochemical expression of estrogene, progesterone receptors, CerbB2 and BRCA1 in ovarian carcinoma and their prognostic value

被引：0
|
作者：
Gursoy, D. [1 ]
Gurses, I. [1 ]
Dunikan, H. [1 ]
Ozcomert, B. [1 ]
Tasdelen, B. [1 ]
Arican, A. [1 ]
Tok, F. [1 ]
机构：
[1] Van Educ Res Hosp, Dept Pathol, Van, Turkey
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
EPS-07-056
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [1] The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection
    Hjortkjaer, Mette
    Waldstrom, Marianne
    Jakobsen, Anders
    Kanstrup, Hanne
    Sogaard-Andersen, Erik
    Steffensen, Karina Dahl
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2017, 36 (02) : 180 - 189
  • [2] SURVIVAL AND BRCA1 EXPRESSION IN EPITHELIAL OVARIAN CARCINOMA - IMMUNOHISTOCHEMICAL DETECTION
    Hjortkjaer, M.
    Waldstrom, M.
    Kanstrup, H.
    Sogaard-Andersen, E.
    Jakobsen, A.
    Steffensen, K. D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 260 - 261
  • [3] BRCA1/2 mRNA EXPRESSION AS A PROGNOSTIC FACTOR IN OVARIAN CANCER
    Tsibulak, I.
    Berger, A.
    Azim, S. Abdel
    Shivalingaiah, G.
    Wenzel, S.
    Wiedemair, A.
    Fiegl, H.
    Marth, C.
    Zeimet, A. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 549 - 549
  • [4] BRCA1/2 MRNA EXPRESSION AS A PROGNOSTIC FACTOR IN OVARIAN CANCER
    Tsibulak, I.
    Berger, A.
    Azim, S. Abdel
    Shivalingaiah, G.
    Wenzel, S.
    Wiedemair, A.
    Fiegl, H.
    Marth, C.
    Zeimet, A. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1694 - 1694
  • [5] Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma
    Majdak, EJ
    Debniak, J
    Milczek, T
    Cornelisse, CJ
    Devilee, P
    Emerich, J
    Jassem, J
    De Bock, GH
    CANCER, 2005, 104 (05) : 1004 - 1012
  • [6] BRCA1 AND PARP 1 IMMUNOHISTOCHEMICAL EXPRESSION IN OVARIAN CANCER.
    Resta, L.
    Cascarano, M. A.
    Serio, G.
    Cormio, G.
    Zannoni, G.
    Arciulo, D.
    Cicinelli, E.
    Loizzi, V.
    Marzullo, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 513 - 513
  • [7] Immunohistochemical expression of BRCA1 in invasive ductal carcinoma of the breast
    Burkadze, G.
    Tsikhiseli, G.
    Khardzeishvili, O.
    Gudadze, M.
    Gachechiladze, M.
    Turashvili, G.
    HISTOPATHOLOGY, 2010, 57 : 30 - 30
  • [8] BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma
    Beirne, J. P.
    Quinn, J. E.
    Maxwell, P.
    Kalloger, S.
    Gilkes, C. B.
    McAlpine, J.
    Harley, I. J. G.
    McCluggage, W. G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 : 232 - 232
  • [9] BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma
    Beirne, James P.
    Quinn, Jennifer E.
    Maxwell, Perry
    Kalloger, Steve E.
    McAlpine, Jessica
    Gilks, C. Blake
    Harley, Ian J. G.
    McCluggage, W. Glenn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (01) : 113 - 118
  • [10] Prognostic value of BRCA1 promoter methylation for patients with epithelial ovarian cancer
    Azais, Henri
    Garinet, Simon
    Benoit, Louise
    de Jesus, Julie
    Zizi, Mohamed
    Landman, Samuel
    Bats, Anne-Sophie
    Taly, Valerie
    Laurent-Puig, Pierre
    Blons, Helene
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (07)
12345